Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Market Cap	2.78B
Revenue (ttm)	1.30B
Net Income (ttm)	400.85M
Shares Out	22.75M
EPS (ttm)	17.62
PE Ratio	6.93
Forward PE	n/a
Dividend	4.00 (3.28%)
Ex-Dividend Date	Nov 13, 2024

Volume	233,931
Average Volume	389,448
Open	123.31
Previous Close	123.31
Day's Range	121.52 - 127.00
52-Week Range	32.91 - 129.88
Beta	0.20
RSI	77.13
Earnings Date	Sep 14, 2025

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In 2024, EGX:MPCI's revenue was 871.91 million, an increase of 31.34% compared to the previous year's 663.83 million. Earnings were 191.46 million, an increase of 111.70%.